nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.246	0.542	CbGaD
Thioridazine—HTR2A—chronic obstructive pulmonary disease	0.207	0.458	CbGaD
Thioridazine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0601	0.157	CbGbCtD
Thioridazine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0439	0.115	CbGbCtD
Thioridazine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0323	0.0846	CbGbCtD
Thioridazine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0323	0.0846	CbGbCtD
Thioridazine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0292	0.0765	CbGbCtD
Thioridazine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0269	0.0704	CbGbCtD
Thioridazine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0269	0.0704	CbGbCtD
Thioridazine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0254	0.0664	CbGbCtD
Thioridazine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0246	0.0643	CbGbCtD
Thioridazine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0246	0.0643	CbGbCtD
Thioridazine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0219	0.0574	CbGbCtD
Thioridazine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0204	0.0533	CbGbCtD
Thioridazine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0136	0.0355	CbGbCtD
Thioridazine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00673	0.29	CbGeAlD
Thioridazine—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00392	0.169	CbGeAlD
Thioridazine—Ileus paralytic—Tiotropium—chronic obstructive pulmonary disease	0.00249	0.0357	CcSEcCtD
Thioridazine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00244	0.105	CbGeAlD
Thioridazine—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.00233	0.0334	CcSEcCtD
Thioridazine—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.024	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00155	0.0221	CcSEcCtD
Thioridazine—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.022	CcSEcCtD
Thioridazine—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.0162	CcSEcCtD
Thioridazine—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.0154	CcSEcCtD
Thioridazine—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.000991	0.0142	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00088	0.0126	CcSEcCtD
Thioridazine—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.00086	0.0123	CcSEcCtD
Thioridazine—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.00086	0.0123	CcSEcCtD
Thioridazine—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.000851	0.0122	CcSEcCtD
Thioridazine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.0108	CcSEcCtD
Thioridazine—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.000744	0.0106	CcSEcCtD
Thioridazine—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.000717	0.0103	CcSEcCtD
Thioridazine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000702	0.01	CcSEcCtD
Thioridazine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000694	0.00992	CcSEcCtD
Thioridazine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000694	0.00992	CcSEcCtD
Thioridazine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000685	0.0098	CcSEcCtD
Thioridazine—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000659	0.0284	CbGeAlD
Thioridazine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.00937	CcSEcCtD
Thioridazine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000623	0.0269	CbGeAlD
Thioridazine—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.000619	0.00885	CcSEcCtD
Thioridazine—HTR7—connective tissue—chronic obstructive pulmonary disease	0.00058	0.025	CbGeAlD
Thioridazine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000546	0.00781	CcSEcCtD
Thioridazine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000546	0.00781	CcSEcCtD
Thioridazine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000535	0.00765	CcSEcCtD
Thioridazine—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000534	0.00763	CcSEcCtD
Thioridazine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000532	0.00761	CcSEcCtD
Thioridazine—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.00053	0.0229	CbGeAlD
Thioridazine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00053	0.00758	CcSEcCtD
Thioridazine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000525	0.0227	CbGeAlD
Thioridazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000523	0.00748	CcSEcCtD
Thioridazine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00738	CcSEcCtD
Thioridazine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000513	0.00734	CcSEcCtD
Thioridazine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000504	0.00721	CcSEcCtD
Thioridazine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000502	0.00719	CcSEcCtD
Thioridazine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000492	0.0212	CbGeAlD
Thioridazine—HTR7—trachea—chronic obstructive pulmonary disease	0.000487	0.021	CbGeAlD
Thioridazine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000484	0.00692	CcSEcCtD
Thioridazine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000477	0.00682	CcSEcCtD
Thioridazine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00679	CcSEcCtD
Thioridazine—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000473	0.0204	CbGeAlD
Thioridazine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000468	0.0067	CcSEcCtD
Thioridazine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000465	0.00665	CcSEcCtD
Thioridazine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00658	CcSEcCtD
Thioridazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.00657	CcSEcCtD
Thioridazine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000451	0.00645	CcSEcCtD
Thioridazine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00641	CcSEcCtD
Thioridazine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000444	0.00636	CcSEcCtD
Thioridazine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000433	0.0187	CbGeAlD
Thioridazine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000431	0.00616	CcSEcCtD
Thioridazine—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.00616	CcSEcCtD
Thioridazine—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000431	0.00616	CcSEcCtD
Thioridazine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000425	0.0183	CbGeAlD
Thioridazine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000419	0.00599	CcSEcCtD
Thioridazine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000411	0.0177	CbGeAlD
Thioridazine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000398	0.0057	CcSEcCtD
Thioridazine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000398	0.0172	CbGeAlD
Thioridazine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000396	0.0171	CbGeAlD
Thioridazine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00559	CcSEcCtD
Thioridazine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00559	CcSEcCtD
Thioridazine—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00558	CcSEcCtD
Thioridazine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000389	0.00557	CcSEcCtD
Thioridazine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00556	CcSEcCtD
Thioridazine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000386	0.00552	CcSEcCtD
Thioridazine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000385	0.00551	CcSEcCtD
Thioridazine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.0055	CcSEcCtD
Thioridazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000383	0.00548	CcSEcCtD
Thioridazine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00548	CcSEcCtD
Thioridazine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00548	CcSEcCtD
Thioridazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000381	0.00545	CcSEcCtD
Thioridazine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000376	0.00537	CcSEcCtD
Thioridazine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00537	CcSEcCtD
Thioridazine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00527	CcSEcCtD
Thioridazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000363	0.0052	CcSEcCtD
Thioridazine—HRH1—trachea—chronic obstructive pulmonary disease	0.000363	0.0157	CbGeAlD
Thioridazine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00517	CcSEcCtD
Thioridazine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000362	0.0156	CbGeAlD
Thioridazine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000357	0.0154	CbGeAlD
Thioridazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.0051	CcSEcCtD
Thioridazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000356	0.0051	CcSEcCtD
Thioridazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000355	0.00507	CcSEcCtD
Thioridazine—HTR7—lung—chronic obstructive pulmonary disease	0.00035	0.0151	CbGeAlD
Thioridazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.005	CcSEcCtD
Thioridazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00035	0.005	CcSEcCtD
Thioridazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000349	0.00499	CcSEcCtD
Thioridazine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00497	CcSEcCtD
Thioridazine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00497	CcSEcCtD
Thioridazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000342	0.0049	CcSEcCtD
Thioridazine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00487	CcSEcCtD
Thioridazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00482	CcSEcCtD
Thioridazine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000331	0.0143	CbGeAlD
Thioridazine—DRD2—lung—chronic obstructive pulmonary disease	0.000331	0.0143	CbGeAlD
Thioridazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00472	CcSEcCtD
Thioridazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.00471	CcSEcCtD
Thioridazine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.0047	CcSEcCtD
Thioridazine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00465	CcSEcCtD
Thioridazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00461	CcSEcCtD
Thioridazine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00444	CcSEcCtD
Thioridazine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00444	CcSEcCtD
Thioridazine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00435	CcSEcCtD
Thioridazine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000304	0.0131	CbGeAlD
Thioridazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00434	CcSEcCtD
Thioridazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00434	CcSEcCtD
Thioridazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000301	0.0043	CcSEcCtD
Thioridazine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000299	0.00427	CcSEcCtD
Thioridazine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00426	CcSEcCtD
Thioridazine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00419	CcSEcCtD
Thioridazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00415	CcSEcCtD
Thioridazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00415	CcSEcCtD
Thioridazine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00412	CcSEcCtD
Thioridazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00409	CcSEcCtD
Thioridazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000283	0.00406	CcSEcCtD
Thioridazine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00405	CcSEcCtD
Thioridazine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.004	CcSEcCtD
Thioridazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000279	0.00399	CcSEcCtD
Thioridazine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000279	0.012	CbGeAlD
Thioridazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00395	CcSEcCtD
Thioridazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00395	CcSEcCtD
Thioridazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00392	CcSEcCtD
Thioridazine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000272	0.0661	CrCbGaD
Thioridazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00387	CcSEcCtD
Thioridazine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000269	0.00385	CcSEcCtD
Thioridazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000266	0.0038	CcSEcCtD
Thioridazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.0038	CcSEcCtD
Thioridazine—HRH1—lung—chronic obstructive pulmonary disease	0.000261	0.0113	CbGeAlD
Thioridazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00373	CcSEcCtD
Thioridazine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00371	CcSEcCtD
Thioridazine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00368	CcSEcCtD
Thioridazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00368	CcSEcCtD
Thioridazine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000256	0.0111	CbGeAlD
Thioridazine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00366	CcSEcCtD
Thioridazine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00366	CcSEcCtD
Thioridazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000256	0.00366	CcSEcCtD
Thioridazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00365	CcSEcCtD
Thioridazine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00363	CcSEcCtD
Thioridazine—CYP2E1—lung—chronic obstructive pulmonary disease	0.000251	0.0108	CbGeAlD
Thioridazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00359	CcSEcCtD
Thioridazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00351	CcSEcCtD
Thioridazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00351	CcSEcCtD
Thioridazine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.0035	CcSEcCtD
Thioridazine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00347	CcSEcCtD
Thioridazine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00347	CcSEcCtD
Thioridazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000242	0.00347	CcSEcCtD
Thioridazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00347	CcSEcCtD
Thioridazine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00346	CcSEcCtD
Thioridazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.00345	CcSEcCtD
Thioridazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00024	0.00344	CcSEcCtD
Thioridazine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00338	CcSEcCtD
Thioridazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00332	CcSEcCtD
Thioridazine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.00023	0.0557	CrCbGaD
Thioridazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00327	CcSEcCtD
Thioridazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00327	CcSEcCtD
Thioridazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00327	CcSEcCtD
Thioridazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00321	CcSEcCtD
Thioridazine—HTR2A—lung—chronic obstructive pulmonary disease	0.000218	0.00941	CbGeAlD
Thioridazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00309	CcSEcCtD
Thioridazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00304	CcSEcCtD
Thioridazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00304	CcSEcCtD
Thioridazine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00303	CcSEcCtD
Thioridazine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00299	CcSEcCtD
Thioridazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00298	CcSEcCtD
Thioridazine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00295	CcSEcCtD
Thioridazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00287	CcSEcCtD
Thioridazine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00282	CcSEcCtD
Thioridazine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00282	CcSEcCtD
Thioridazine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000196	0.0028	CcSEcCtD
Thioridazine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.0028	CcSEcCtD
Thioridazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000196	0.0028	CcSEcCtD
Thioridazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.0028	CcSEcCtD
Thioridazine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000196	0.0028	CcSEcCtD
Thioridazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00278	CcSEcCtD
Thioridazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00278	CcSEcCtD
Thioridazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00278	CcSEcCtD
Thioridazine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00277	CcSEcCtD
Thioridazine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00274	CcSEcCtD
Thioridazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00274	CcSEcCtD
Thioridazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00273	CcSEcCtD
Thioridazine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00269	CcSEcCtD
Thioridazine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00267	CcSEcCtD
Thioridazine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00264	CcSEcCtD
Thioridazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00264	CcSEcCtD
Thioridazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00264	CcSEcCtD
Thioridazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00264	CcSEcCtD
Thioridazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00263	CcSEcCtD
Thioridazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00258	CcSEcCtD
Thioridazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00249	CcSEcCtD
Thioridazine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00241	CcSEcCtD
Thioridazine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.0408	CrCbGaD
Thioridazine—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.0408	CrCbGaD
Thioridazine—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.000165	0.0399	CrCbGaD
Thioridazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00235	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00233	CcSEcCtD
Thioridazine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.0022	CcSEcCtD
Thioridazine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00216	CcSEcCtD
Thioridazine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00214	CcSEcCtD
Thioridazine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.000147	0.0358	CrCbGaD
Thioridazine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000146	0.0354	CrCbGaD
Thioridazine—Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.0352	CrCbGaD
Thioridazine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.000144	0.035	CrCbGaD
Thioridazine—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.000142	0.0344	CrCbGaD
Thioridazine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.000142	0.0344	CrCbGaD
Thioridazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00202	CcSEcCtD
Thioridazine—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.00014	0.034	CrCbGaD
Thioridazine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00198	CcSEcCtD
Thioridazine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00198	CcSEcCtD
Thioridazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00197	CcSEcCtD
Thioridazine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00196	CcSEcCtD
Thioridazine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.0322	CrCbGaD
Thioridazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.00177	CcSEcCtD
Thioridazine—Fluphenazine—HTR2A—chronic obstructive pulmonary disease	0.000123	0.0297	CrCbGaD
Thioridazine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00175	CcSEcCtD
Thioridazine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.029	CrCbGaD
Thioridazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00171	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00169	CcSEcCtD
Thioridazine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	0.000118	0.0286	CrCbGaD
Thioridazine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00167	CcSEcCtD
Thioridazine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.0282	CrCbGaD
Thioridazine—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.0279	CrCbGaD
Thioridazine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	0.000112	0.0272	CrCbGaD
Thioridazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00152	CcSEcCtD
Thioridazine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00152	CcSEcCtD
Thioridazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00152	CcSEcCtD
Thioridazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00151	CcSEcCtD
Thioridazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00149	CcSEcCtD
Thioridazine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.0251	CrCbGaD
Thioridazine—Acepromazine—ALB—chronic obstructive pulmonary disease	0.000101	0.0245	CrCbGaD
Thioridazine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	0.000101	0.0245	CrCbGaD
Thioridazine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00144	CcSEcCtD
Thioridazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.99e-05	0.00143	CcSEcCtD
Thioridazine—Promethazine—HTR2A—chronic obstructive pulmonary disease	9.93e-05	0.0241	CrCbGaD
Thioridazine—Thioproperazine—ALB—chronic obstructive pulmonary disease	9.86e-05	0.0239	CrCbGaD
Thioridazine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	9.8e-05	0.0238	CrCbGaD
Thioridazine—Thiothixene—ALB—chronic obstructive pulmonary disease	9.7e-05	0.0235	CrCbGaD
Thioridazine—Pipotiazine—ALB—chronic obstructive pulmonary disease	9.7e-05	0.0235	CrCbGaD
Thioridazine—Perphenazine—HTR2A—chronic obstructive pulmonary disease	9.69e-05	0.0235	CrCbGaD
Thioridazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.00138	CcSEcCtD
Thioridazine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	9.11e-05	0.0221	CrCbGaD
Thioridazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9e-05	0.00129	CcSEcCtD
Thioridazine—Promazine—HTR2A—chronic obstructive pulmonary disease	8.74e-05	0.0212	CrCbGaD
Thioridazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.36e-05	0.0012	CcSEcCtD
Thioridazine—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.00111	CcSEcCtD
Thioridazine—Rash—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.0011	CcSEcCtD
Thioridazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.0011	CcSEcCtD
Thioridazine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	7.69e-05	0.0187	CrCbGaD
Thioridazine—Clomipramine—ALB—chronic obstructive pulmonary disease	7.67e-05	0.0186	CrCbGaD
Thioridazine—Headache—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.0011	CcSEcCtD
Thioridazine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.00104	CcSEcCtD
Thioridazine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	5.26e-05	0.0128	CrCbGaD
Thioridazine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.64e-06	0.000142	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.62e-06	0.000141	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.5e-06	0.00014	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.35e-06	0.000137	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.33e-06	0.000137	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.3e-06	0.000137	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.28e-06	0.000136	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.21e-06	0.000135	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.21e-06	0.000135	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.21e-06	0.000135	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.19e-06	0.000135	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.18e-06	0.000135	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.15e-06	0.000135	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.14e-06	0.000134	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.11e-06	0.000134	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.08e-06	0.000134	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.03e-06	0.000133	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.01e-06	0.000133	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9e-06	0.000132	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.98e-06	0.000132	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.98e-06	0.000132	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.85e-06	0.00013	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.85e-06	0.00013	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.8e-06	0.000129	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.79e-06	0.000129	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.74e-06	0.000129	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.73e-06	0.000128	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.72e-06	0.000128	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.55e-06	0.000126	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.52e-06	0.000125	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.5e-06	0.000125	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.49e-06	0.000125	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.46e-06	0.000124	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.42e-06	0.000124	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.41e-06	0.000124	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.41e-06	0.000124	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.4e-06	0.000123	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.4e-06	0.000123	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.37e-06	0.000123	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.35e-06	0.000123	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.34e-06	0.000123	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.33e-06	0.000123	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.33e-06	0.000122	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.3e-06	0.000122	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.29e-06	0.000122	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.26e-06	0.000121	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.25e-06	0.000121	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.24e-06	0.000121	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.22e-06	0.000121	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.2e-06	0.000121	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.18e-06	0.00012	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.05e-06	0.000118	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.96e-06	0.000117	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.95e-06	0.000117	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.86e-06	0.000116	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.82e-06	0.000115	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.82e-06	0.000115	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.78e-06	0.000114	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.77e-06	0.000114	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.76e-06	0.000114	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.72e-06	0.000113	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.7e-06	0.000113	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.66e-06	0.000113	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.65e-06	0.000113	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.64e-06	0.000112	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.64e-06	0.000112	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.62e-06	0.000112	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.6e-06	0.000112	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.59e-06	0.000112	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.58e-06	0.000111	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.57e-06	0.000111	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.52e-06	0.000111	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.5e-06	0.00011	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.49e-06	0.00011	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.48e-06	0.00011	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.45e-06	0.00011	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	7.43e-06	0.000109	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.43e-06	0.000109	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.43e-06	0.000109	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.29e-06	0.000107	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.17e-06	0.000106	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.17e-06	0.000106	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.17e-06	0.000105	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.15e-06	0.000105	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.13e-06	0.000105	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.06e-06	0.000104	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.05e-06	0.000104	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.02e-06	0.000103	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.95e-06	0.000102	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.93e-06	0.000102	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.91e-06	0.000102	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.9e-06	0.000102	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.85e-06	0.000101	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.83e-06	0.0001	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.79e-06	9.99e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.78e-06	9.97e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.76e-06	9.94e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.71e-06	9.87e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.7e-06	9.86e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.67e-06	9.81e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.65e-06	9.78e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.65e-06	9.77e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.46e-06	9.51e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.43e-06	9.46e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.38e-06	9.39e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.38e-06	9.38e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.37e-06	9.37e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.36e-06	9.36e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.31e-06	9.28e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.28e-06	9.24e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.23e-06	9.16e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.18e-06	9.09e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.17e-06	9.07e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.16e-06	9.05e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.14e-06	9.03e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.08e-06	8.93e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.03e-06	8.87e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.89e-06	8.66e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.88e-06	8.64e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.86e-06	8.62e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.85e-06	8.61e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.8e-06	8.53e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	5.79e-06	8.51e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.78e-06	8.5e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.73e-06	8.43e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.73e-06	8.42e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.68e-06	8.35e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.61e-06	8.25e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.59e-06	8.21e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.57e-06	8.19e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.55e-06	8.16e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	5.54e-06	8.14e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.5e-06	8.09e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.5e-06	8.08e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.48e-06	8.06e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.47e-06	8.04e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.42e-06	7.97e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.4e-06	7.93e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.33e-06	7.84e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.32e-06	7.83e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.32e-06	7.82e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	5.32e-06	7.82e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.26e-06	7.74e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.26e-06	7.73e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.23e-06	7.7e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.23e-06	7.68e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.22e-06	7.67e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.2e-06	7.64e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.17e-06	7.6e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.16e-06	7.59e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.15e-06	7.58e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.09e-06	7.48e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.08e-06	7.48e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.08e-06	7.47e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.08e-06	7.47e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5e-06	7.35e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.98e-06	7.33e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.98e-06	7.32e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.97e-06	7.31e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.96e-06	7.29e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.94e-06	7.27e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.94e-06	7.26e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.85e-06	7.13e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.73e-06	6.96e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.73e-06	6.95e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.7e-06	6.91e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.7e-06	6.91e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.63e-06	6.81e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.59e-06	6.76e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.59e-06	6.75e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.53e-06	6.66e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.51e-06	6.64e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.5e-06	6.62e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.5e-06	6.62e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.44e-06	6.53e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.43e-06	6.52e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.42e-06	6.5e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.39e-06	6.46e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.36e-06	6.41e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.33e-06	6.37e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.33e-06	6.36e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.29e-06	6.31e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.28e-06	6.3e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.24e-06	6.24e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.22e-06	6.21e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.21e-06	6.2e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.2e-06	6.18e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.15e-06	6.1e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.11e-06	6.04e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.1e-06	6.03e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.08e-06	6e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.07e-06	5.99e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.04e-06	5.94e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.01e-06	5.89e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4e-06	5.88e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.97e-06	5.83e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.96e-06	5.82e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.92e-06	5.77e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.91e-06	5.74e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.9e-06	5.73e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.88e-06	5.7e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.82e-06	5.62e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.8e-06	5.59e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.77e-06	5.55e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.74e-06	5.5e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.73e-06	5.48e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.73e-06	5.48e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.71e-06	5.46e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.71e-06	5.45e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.67e-06	5.39e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.66e-06	5.38e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.64e-06	5.35e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.61e-06	5.31e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.6e-06	5.29e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.59e-06	5.28e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.58e-06	5.26e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.42e-06	5.03e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.41e-06	5.02e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.37e-06	4.95e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.36e-06	4.94e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.35e-06	4.93e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.34e-06	4.9e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.3e-06	4.86e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.3e-06	4.85e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.29e-06	4.84e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.29e-06	4.84e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.24e-06	4.76e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.23e-06	4.75e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.21e-06	4.72e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.2e-06	4.7e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.19e-06	4.69e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.06e-06	4.5e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.06e-06	4.49e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.05e-06	4.49e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3e-06	4.41e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.94e-06	4.32e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.92e-06	4.29e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.82e-06	4.14e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.8e-06	4.11e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.77e-06	4.07e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.76e-06	4.06e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.72e-06	4e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.71e-06	3.99e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.58e-06	3.79e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.54e-06	3.73e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.53e-06	3.72e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.52e-06	3.71e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.49e-06	3.66e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.48e-06	3.65e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.31e-06	3.39e-05	CbGpPWpGaD
